Department of Cardiology, Elias Emergency Hospital, 011461, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Biopathology and Therapy of Inflammation, Institute of Cellular Biology and Pathology "Nicolae Simionescu", 050568 Bucharest, Romania.
Int J Mol Sci. 2024 May 8;25(10):5107. doi: 10.3390/ijms25105107.
Despite neutrophil involvement in inflammation and tissue repair, little is understood about their inflammatory status in acute coronary syndrome (ACS) patients with poor outcomes. Hence, we investigated the potential correlation between neutrophil inflammatory markers and the prognosis of ACS patients with/without diabetes and explored whether neutrophils demonstrate a unique inflammatory phenotype in patients experiencing an adverse in-hospital outcome. The study enrolled 229 ACS patients with or without diabetes. Poor evolution was defined as either death, left ventricular ejection fraction (LVEF) <40%, Killip Class 3/4, ventricular arrhythmias, or mechanical complications. Univariate and multivariate analyses were employed to identify clinical and paraclinical factors associated with in-hospital outcomes. Neutrophils isolated from fresh blood were investigated using qPCR, Western blot, enzymatic assay, and immunofluorescence. Poor evolution post-myocardial infarction (MI) was associated with increased number, activity, and inflammatory status of neutrophils, as indicated by significant increase of Erythrocyte Sedimentation Rate (ESR), C-reactive protein (CRP), fibrinogen, interleukin-1β (IL-1β), and, interleukin-6 (IL-6). Among the patients with complicated evolution, neutrophil activity had an important prognosis value for diabetics. Neutrophils from patients with unfavorable evolution revealed a pro-inflammatory phenotype with increased expression of , , , , , , of molecules essential in reactive oxygen species (ROS) production and , and increased capacity to form neutrophil extracellular traps. Inflammation is associated with adverse short-term prognosis in acute ACS, and inflammatory biomarkers exhibit greater specificity in predicting short-term outcomes in diabetics. Moreover, neutrophils from patients with unfavorable evolution exhibit distinct inflammatory patterns, suggesting that alterations in the innate immune response in this subgroup may exert detrimental effects on disease progression.
尽管中性粒细胞参与炎症和组织修复,但人们对其在预后不良的急性冠状动脉综合征(ACS)患者中的炎症状态知之甚少。因此,我们研究了中性粒细胞炎症标志物与 ACS 合并或不合并糖尿病患者预后之间的潜在相关性,并探讨了在经历不良院内结局的患者中,中性粒细胞是否表现出独特的炎症表型。该研究纳入了 229 例合并或不合并糖尿病的 ACS 患者。不良转归定义为死亡、左心室射血分数(LVEF)<40%、Killip 分级 3/4、室性心律失常或机械并发症。采用单因素和多因素分析确定与院内结局相关的临床和临床前因素。使用 qPCR、Western blot、酶活性测定和免疫荧光法检测新鲜血液中分离的中性粒细胞。心肌梗死后(MI)不良转归与中性粒细胞数量、活性和炎症状态增加相关,红细胞沉降率(ESR)、C 反应蛋白(CRP)、纤维蛋白原、白细胞介素-1β(IL-1β)和白细胞介素-6(IL-6)显著增加。在复杂转归的患者中,中性粒细胞活性对糖尿病患者具有重要的预后价值。不良转归患者的中性粒细胞呈现促炎表型,表现为关键的活性氧(ROS)产生分子、和的表达增加,和的形成能力增加,以及中性粒细胞胞外诱捕网的形成能力增加。炎症与急性 ACS 的不良短期预后相关,炎症生物标志物在预测糖尿病患者的短期预后方面具有更高的特异性。此外,不良转归患者的中性粒细胞表现出独特的炎症模式,表明该亚组中固有免疫反应的改变可能对疾病进展产生不利影响。